These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35709149)

  • 1. An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol.
    Garakani A; Freire RC; Buono FD; Thom RP; Larkin K; Funaro MC; Salehi M; Perez-Rodriguez MM
    PLoS One; 2022; 17(6):e0269772. PubMed ID: 35709149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic agents in anxiety disorders: An umbrella review.
    Garakani A; Buono FD; Salehi M; Funaro MC; Klimowicz A; Sharma H; Faria CGF; Larkin K; Freire RC
    Acta Psychiatr Scand; 2024 Apr; 149(4):295-312. PubMed ID: 38382649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of atypical antipsychotics in the treatment of generalized anxiety disorder.
    Hershenberg R; Gros DF; Brawman-Mintzer O
    CNS Drugs; 2014 Jun; 28(6):519-33. PubMed ID: 24794100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antipsychotics for anxiety disorders.
    Depping AM; Komossa K; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008120. PubMed ID: 21154392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
    Lorenz RA; Jackson CW; Saitz M
    Pharmacotherapy; 2010 Sep; 30(9):942-51. PubMed ID: 20795849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
    Bandelow B
    Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
    Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
    Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for generalized anxiety disorder in adults: an update.
    Reinhold JA; Rickels K
    Expert Opin Pharmacother; 2015; 16(11):1669-81. PubMed ID: 26159446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation antipsychotics for obsessive compulsive disorder.
    Komossa K; Depping AM; Meyer M; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008141. PubMed ID: 21154394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
    Gao K; Muzina D; Gajwani P; Calabrese JR
    J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
    Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
    Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.
    Pignon B; Tezenas du Montcel C; Carton L; Pelissolo A
    Curr Psychiatry Rep; 2017 Nov; 19(12):103. PubMed ID: 29110139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
    Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
    Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
    Ann Clin Psychiatry; 2014 Feb; 26(1):3-18. PubMed ID: 24660224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials.
    Maneeton N; Maneeton B; Woottiluk P; Likhitsathian S; Suttajit S; Boonyanaruthee V; Srisurapanont M
    Drug Des Devel Ther; 2016; 10():259-76. PubMed ID: 26834458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.